Personal Information
- Full Name: Dr. Sanjay Kumar Bharti
- Mobile Number: 9301808566
- EmailID: sanjay.itbhu@gmail.com
- Designation: Associate Professor
Qualification
-
2011Ph. D.
IIT(BHU)-Varanasi
-
2006M. Pharm.
RGPV, Bhopal
-
2003B. Pharm.
IIT(BHU)-Varanasi
Experience
-
2024 - 2025Associate Professor
Guru Ghasidas Vishwavidyalaya (A Central University)
-
2012 - 2024Assistant Professor
Guru Ghasidas Vishwavidyalaya (A Central University)
-
2010 - 2012Lecturer
National Institute of Pharmaceutical Education and Research (NIPER), Hajipur
Doctoral Theses Guided
Design, synthesis and biological evaluation of newer thiazolidine-2,4-diones as anticancer agents
-
Guru Ghasidas Vishwavidyalaya (A Central University)
-
Mr. Vivek Asati
Research Projects
Design and synthesis of some novel metal (Co, Ni, Ga) complexes of bi-/tridentate ligand(s) as potential nucleolytic and anticancer agents
Completed Amount: ₹6.00
Funding Agency: UGC, New Delhi
Duration : 01:04:2013 - 31:03:2015
Publications
An updated patent review on rational combinations of HDAC inhibitors for cancer chemotherapy (2020 – present): part 1-patent granted
Yugal Kishor Shukla, Vandana, Vivekananda Mandal, Vivek Asati, Raj K. Keservani, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Expert Opinion on Therapeutic Patents
Year: 2025
DOI: https://doi.org/10.1080/13543776.2025.2546595
Impact Factor: 5.40
An updated patent review on rational combinations of HDAC inhibitors for cancer chemotherapy (2020 – present): part 2 - patent published
Yugal Kishor Shukla, Vandana, Vivekananda Mandal, Vivek Asati, Raj K. Keservani, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Expert Opinion on Therapeutic Patents
Volume: 35(8)
Year: 2025
Pages: 875–900
Impact Factor: 5.40
Structural aspects of HIV-1 integrase inhibitors: SAR studies and synthetic strategies
Barik, Pallavi, Shankar Gupta, Gurpreet Singh, Sanjay Kumar Bharti, and Vivek Asati
Publication Type: Journal Article (International)
Journal: Molecular Diversity
Volume: 29
Year: 2025
Pages: 4963–4997
DOI: https://doi.org/10.1007/s11030-024-11068-4
Impact Factor: 3.80
MEK Inhibitors in Oncology: A Patent Review and Update (2016 – Present)
Anjali Suryavanshi, Vandana, Yugal Kishor Shukla, Vipul Kumar, Pragya Gupta, Vivek Asati, Debarshi Kar Mahapatra, Raj K. Keservani, Sanmati Kumar Jain, and Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Expert Opinion on Therapeutic Patents
Volume: 34
Year: 2024
Pages: 963–1007
DOI: https://doi.org/10.1080/13543776.2024.2403634
Impact Factor: 4.60
PIM Kinase Inhibitors: An Updated Patent Review (2016-Present)
Anushka Sharma, Rahul Dubey, Shankar Gupta, Vivek Asati, Vipul Kumar, Dileep Kumar, Debarshi Kar Mahapatra, Meenakshi Jaiswal, Sanmati Kumar Jain, and Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: . Expert Opinion on Therapeutic Patents
Volume: 34
Year: 2024
Pages: 365–82
DOI: doi: 10.1080/13543776.2024.2365411
Impact Factor: 4.60
Recent Advances in the Treatment and Management of Alzheimer’s Disease: A Precision Medicine Perspective
Deepali Shukla, Anjali Suryavanshi, Sanjay Kumar Bharti*, Vivek Asati and Debarshi Kar Mahapatra
Publication Type: Journal Article (International)
Journal: Current Topics in Medicinal Chemistry
Volume: 24
Year: 2024
Pages: 1699-1737
DOI: doi: 10.2174/0115680266299847240328045737
Impact Factor: 2.90
3D-QSAR and Pharmacophoric study on 2,6-Disubstituted Thiazolo [4,5-b] Pyridines as H3 Receptor Antagonists
S. K. Jain, S. K. Bharti, B.G.V.S. Jagan, Ajay K. Gupta
Publication Type: Journal Article (International)
Journal: Research Journal of Pharmacy and Technology (RJPT),
Volume: 16
Year: 2023
Pages: 4575-4582
DOI: 10.52711/0974-360X.2023.00745
Recent advances of PI3 Kinase inhibitors: Structure anticancer activity relationship studies
Asati Vivek, Anant Arjun, Mahapatra Kar Debarshi and Bharti Kumar Sanjay
Publication Type: Journal Article (International)
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22
Year: 2022
Pages: 2146 - 2165
DOI: doi: 10.2174/1389450123666220202154757.
Impact Factor: 3.80
Discovery of novel ALK2 inhibitors of pyrazolo-pyrimidines: A computational study
Vivek Asati, Sanjay K. Bharti, Ratnesh Das, Varsha Kashaw & Sushil Kumar Kashaw
Publication Type: Journal Article (International)
Journal: Journal of Biomolecular Structure and Dynamics
Volume: 40
Year: 2022
Pages: 10422-10436
DOI: 10.1080/07391102.2021.1944320
Impact Factor: 5.30
Recent progress in theranostic nanoparticles for personalized medicine,
Krishna Kant Jangde, Anjali Suryavanshi, Deepali Shukla, Meenakshi Jaiswal, Vipul Kumar, Sanjay Kumar Bharti
Publication Type: Journal Article (National)
Journal: Chhattisgarh Journal of Science and Technology
Volume: 19
Year: 2022
Pharmacovigilance in digital era: real-world data and safety monitoring
Vipul Kumar, Sanjay Kumar Bharti*, Deepali Shukla, Anjali Suryavanshi, Krishna Kant Jangde, Karthikeyan Kesavan, Vivek Asati, Debarshi Kar Mahapatra , Raj K. Keservani
Publication Type: Journal Article (National)
Journal: Chhattisgarh Journal of Science and Technology
Volume: 28
Year: 2021
Pages: 1197–1202
DOI: 10.1002/cpt.2172
Synthesis, Characterized and Biological Evaluation of Some Novel Schiff Bases,
None
Publication Type: Journal Article (International)
Journal: International Research Journal of Engineering and Technology (IRJET),
Volume: 8
Year: 2021
Pages: 931-939
Current discovery progress of some emerging anti-infective chalcones
13. Debarshi Kar Mahapatra, Soumajit Ghorai, Sanjay Kumar Bharti, Asmita Gajbhiye Patil and Shovanlal Gayen,
Publication Type: Journal Article (International)
Journal: Current Drug Discovery Technologies
Volume: 17
Year: 2020
Pages: 30-44
DOI: 10.2174/1570163815666180720170030
An updated patent review of therapeutic applications of chalcone derivatives (2014-present),
Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Expert Opinion on Therapeutic Patents
Volume: 29
Year: 2019
Pages: 385-406
DOI: 10.1080/13543776.2019.1613374
Impact Factor: 6.60
Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications
Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Vivek Asati, Sushil Kumar Singh
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 174
Year: 2019
Pages: 142-158
DOI: https://doi.org/10.1016/j.ejmech.2019.04.032
Impact Factor: 7.00
PIM Kinase Inhibitors: Structural and Pharmacological Perspectives.
Vivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 15
Year: 2019
Pages: 172:95-108
DOI: doi: 10.1016/j.ejmech.2019.03.050.
Impact Factor: 7.00
3D-QSAR and molecular docking studies on oxadiazole substituted benzimidazole derivatives: Validation of experimental inhibitory potencies towards COX-2,
Vivek Asati, Piyush Ghode, Shalini Bajaj, Sanmati Kumar Jain, Sanjay Kumar Bharti*,
Publication Type: Journal Article (International)
Volume: 15
Year: 2019
Pages: 277-293
DOI: doi: 10.2174/1573409914666181003153249.
Impact Factor: 1.60
Recent therapeutic progress of chalcone scaffold bearing compounds as prospective anti-gout candidates
Debarshi Kar Mahapatra, Vivek Asati, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Journal of Critical Reviews
Volume: 6
Year: 2019
Pages: 1-5
DOI: 10.22159/jcr.2019v6i1.31760
Impact Factor: 1.40
Nutritional advantages and effects of vitamins in human health
Khemchand R. Surana , Eknath D. Ahire, Raj K. Keservani, Arvind Kumar Gupta, Meenendra Tripathi, Akanksha Yadav, Sanjay K. Bharti5*, Brijesh Kumar Singh, Nagendra Shukla
Publication Type: Journal Article (National)
Journal: Chhattisgarh Journal of Science and Technology
Volume: 16
Year: 2019
Pages: 67-70
Virtual Screening, Molecular Docking, and DFT Studies of Some Thiazolidine-2,4-diones as Potential PIM-1 Kinase Inhibitors,
None
Publication Type: Journal Article (International)
Journal: ChemistrySelect
Volume: 3
Year: 2018
Pages: 12186-12194
DOI: https://doi.org/10.1002/slct.201702392
Impact Factor: 2.30
Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents
Vivek Asati, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Journal of Molecular Structure
Volume: 1154
Year: 2018
Pages: 406-417
DOI: https://doi.org/10.1016/j.molstruc.2017.10.077
Impact Factor: 3.80
Overview on gastro retentive drug delivery systems: Current scenario and future prospective
Rashmi Chourasiya, Meenakshi Jaiswal, Sanjay Kumar Bharti , Sanmati Kumar Jain , Ajay Kumar Gupta , Nidhi Agrawal
Publication Type: Journal Article (National)
Journal: Chhattisgarh Journal of Science and Technology
Volume: 15
Year: 2018
Pages: 132-135
Microwave in synthetic chemistry: a green chemistry approach,
Sanjay Kumar Bharti1* , Meenakshi Jaiswal , N.S. Hari Narayana Moorthy
Publication Type: Journal Article (National)
Journal: Chhattisgarh Journal of Science and Technology
Volume: 15
Year: 2018
Pages: 124-131
Design, microwave assisted synthesis and characterization of benzimidazolin-2-one and its derivatives,
Sanjay Kumar Bharti1* , Meenakshi Jaiswal , N.S. Hari Narayana Moorthy
Publication Type: Journal Article (National)
Journal: Chhattisgarh Journal of Science and Technology
Volume: 15
Year: 2018
Pages: 92-96
MEK inhibitors in oncology: a patent review (2015-Present),
Debarshi Kar Mahapatra, Vivek Asati and Sanjay Kumar Bharti*
Publication Type: Journal Article (International)
Journal: Expert Opinion on Therapeutic Patents
Volume: 27
Year: 2017
Pages: 887-906
DOI: 10.1080/13543776.2017.1339688.
Impact Factor: 6.60
Chalcone derivatives: anti-inflammatory potential and molecular targets perspectives
Debarshi Kar Mahapatra, Sanjay Kumar Bharti* and Vivek Asati
Publication Type: Journal Article (International)
Journal: Current Topics in Medicinal Chemistry
Volume: 17
Year: 2017
Pages: 3146-3169.
DOI: 10.2174/1568026617666170914160446.
Impact Factor: 3.57
Nature inspired green fabrication technology for silver nanoparticles
Debarshi Kar Mahapatra*, Sanjay Kumar Bharti, Vivek Asati,
Publication Type: Journal Article (International)
Journal: Current Nanomedicine
Volume: 7
Year: 2017
Pages: 5-24
DOI: https://doi.org/10.2174/2468187306666160927122028
K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives,
Vivek Asati, Debarshi Kar Mahapatra and Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 125
Year: 2017
Pages: 299-314
DOI: https://doi.org/10.1016/j.ejmech.2016.09.049
Impact Factor: 7.00
3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase
Vivek Asati, Sanjay Kumar Bharti, Ashok Kumar Budhwani
Publication Type: Journal Article (International)
Journal: Journal of Molecular Structure
Volume: 11335
Year: 2017
Pages: 278-293
DOI: https://doi.org/10.1016/j.molstruc.2016.12.006
Impact Factor: 3.84
SWFB and GA strategies for variable selection in QSAR studies for the validation of thiazolidine-2,4-dione derivatives as promising antitumor candidates
Vivek Asati, Sanjay Kumar Bharti, Ankita Rathore, Debarshi Kar Mahapatra
Publication Type: Journal Article (National)
Journal: Indian Journal of Pharmaceutical Education and Research
Volume: 51
Year: 2017
Pages: 436-451
DOI: doi:10.5530/ijper.51.3.72
Impact Factor: 0.60
Novel Murrayanine based Pyrazole analogs as emerging anti-fungal candidates: Design, synthesis, characterization, and in vitro evaluation
Debarshi Kar Mahapatra, Ruchi S. Shivhare, Sanjay K. Bharti
Publication Type: Journal Article (International)
Journal: Research Pharmaceutica
Volume: 1
Year: 2017
Pages: 1-5
Molecular Modeling Studies of Some Thiazolidine-2, 4-dione Derivatives as 15-PGDH Inhibitors
Vivek Asati, Shalini Bajaj, Debarshi Kar Mahapatra, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Medicinal Chemistry Research
Volume: 25
Year: 2016
Pages: 94-108
DOI: https://doi.org/10.1007/s00044-015-1442-5
Impact Factor: 2.50
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK Signaling Pathways Inhibitors as Anticancer Agents: Structural and Pharmacological Perspectives
Vivek Asati, Debarshi Kar Mahapatra, Sanjay Kumar Bharti*,
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 109
Year: 2016
Pages: 314-341
DOI: https://doi.org/10.1016/j.ejmech.2016.01.012
Impact Factor: 7.00
Therapeutic Potential of Chalcones as Cardiovascular Agents
Debarshi Kar Mahapatra, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Life Science
Volume: 148
Year: 2016
Pages: 154–172
DOI: https://doi.org/10.1016/j.lfs.2016.02.048
Impact Factor: 6.70
QSAR studies for some thiazolidine-2,4-dione derivatives as PIM-2 kinase inhibitors
Vivek Asati*, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Medicinal Chemistry Research
Volume: 25
Year: 2016
Pages: 1329-1339
DOI: https://doi.org/10.1007/s00044-016-1577-z
Impact Factor: 2.35
Mutant B-Raf Kinase inhibitors as anticancer agents
Vivek Asati*, Sanjay Kumar Bharti, Debarshi Kar Mahapatra
Publication Type: Journal Article (International)
Journal: Anti-cancer agents in medicinal chemistry
Volume: 16
Year: 2016
Pages: 1558-1575
DOI: 10.2174/1871520616666160606101848
Impact Factor: 2.50
Triggering PIK3CA mutations in PI3K/AKT/mTOR axis: Exploration of newer inhibitors and rational preventive strategies
Vivek Asati, Sanjay Kumar Bharti, Debarshi Kar Mahapatra, Ashok Kumar Budhwani
Publication Type: Journal Article (International)
Journal: Current Pharmaceutical Design
Volume: 22
Year: 2016
Pages: 6039-6054
DOI: 10.2174/1381612822666160614000053
Impact Factor: 3.30
Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives
Debarshi Kar Mahapatra, Sanjay Kumar Bharti*, Vivek Asati,
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 101
Year: 2015
Pages: 496-524
DOI: https://doi.org/10.1016/j.ejmech.2015.06.052
Impact Factor: 7.00
Anti-cancer chalcones: Structural and molecular target perspectives
Debarshi Kar Mahapatra, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 98
Year: 2015
Pages: 69-114
DOI: https://doi.org/10.1016/j.ejmech.2015.05.004
Impact Factor: 7.00
Chalcones and Their Therapeutic Targets for the Management of Diabetes: Structural and Pharmacological Perspectives
Debarshi Kar Mahapatra, Vivek Asati, Sanjay K. Bharti
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 92
Year: 2015
Pages: 839-865
DOI: https://doi.org/10.1016/j.ejmech.2015.01.051
Impact Factor: 7.00
Mutations in surface protein of swine flu: A major problem for H1N1 inhibitor
Mukesh Kumar Gupta, J.S. Dangi, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Asian Journal of Biomedical and Pharmaceutical Sciences
Volume: 5
Year: 2015
Pages: 1-9
Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents
Vivek Asati, Debarshi Kar Mahapatra, Sanjay K. Bharti
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 87
Year: 2014
Pages: 814 – 833
DOI: https://doi.org/10.1016/j.ejmech.2014.10.025
Impact Factor: 7.00
Design, synthesis and biological evaluation of some novel benzylidene-2-(4-phenylthiazol-2-yl) hydrazines as potential anti-inflammatory agents,
Sanjay K. Bharti*, Sushil K. Singh
Publication Type: Journal Article (International)
Journal: Medicinal Chemistry Research
Volume: 23
Year: 2014
Pages: 1004-1015
DOI: https://doi.org/10.1007/s00044-013-0708-z
Impact Factor: 2.30
Drug of choice for swine flu: a challenge ahead
Mukesh Kumar Gupta, Jawahar Singh Dangi, Sanjay Kumar Bharti, Krisna Gopal P
Publication Type: Journal Article (International)
Journal: Asian Journal of Pharmaceutical Sciences and Research
Volume: 3
Year: 2013
Pages: 01-18
Histamine H4 Receptor: A Novel Target for Inflammation Therapy
C. Saravanan, Sanjay Kumar Bharti, S. Jaggi, S. K. Singh
Publication Type: Journal Article (International)
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11
Year: 2011
Pages: 143 - 158
DOI: DOI: 10.2174/138955711794519519
Impact Factor: 3.80
Pharmacogeomics in clinical research and practice: An ethical consideration
Ajay Verma*, Tanu Khurana, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Pharmacologyonline,
Volume: 1
Year: 2011
Pages: 453-461
Homology modeling and molecular dynamics study of serine hydroxyl methyl transferase enzyme from Leishmania donovani
Ashish Sethi, Rakesh Kumar Sharma, Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Journal of Pharmacy Research
Volume: 4
Year: 2011
Pages: 2269-2272
Synthesis, characterization, DNA cleavage and in vitro antimicrobial activities of novel copper(II) complexes of Schiff bases containing a 2,4-disubstituted thiazole
Sanjay Kumar Bharti, Saurabh K. Patel, Gopal Nath, Ragini Tilak, Sushil K. Singh*,
Publication Type: Journal Article (International)
Journal: Transition Metal Chemistry
Volume: 35
Year: 2010
Pages: 917 – 925
DOI: https://doi.org/10.1007/s11243-010-9412-8
Impact Factor: 1.60
Synthesis, antibacterial and antifungal activities of some novel Schiff bases containing 2, 4-disubstituted thiazole ring
Sanjay Kumar Bharti, G. Nath, R. Tilak and S. K. Singh
Publication Type: Journal Article (International)
Journal: European Journal of Medicinal Chemistry
Volume: 45
Year: 2010
Pages: 651 – 660
DOI: https://doi.org/10.1016/j.ejmech.2009.11.008
Impact Factor: 7.00
2D – Quantitative Structure Property Relationship (QSPR) Study of N-(aryl)-2-thiophen-2-ylacetamide Derivatives as Antitubercular Agents
Hemendra Singh Chouhan, Sanjay Kumar Bharti, Sushil K. Singh
Publication Type: Journal Article (International)
Journal: Asian Journal of Chemistry
Volume: 22
Year: 2010
Pages: 4675-4680
Synthesis and Evaluation of N-Mannich bases of Isatin-3- (4- aldehyde/ketone 2-thiosemicarbazones) derivatives as potent anticonvulsant agents
S. K. Singh, S. Jaggi, Sanjay Kumar Bharti and R. G. Kulkarni
Publication Type: Journal Article (International)
Journal: Acta Pharmaceutica Sciencia
Volume: 51
Year: 2009
Pages: 47-55
Metal Based Drugs: Current Use and Future Potential
Sanjay Kumar Bharti* and Sushil K. Singh
Publication Type: Journal Article (International)
Journal: Der Pharmacia Lettre
Volume: 1
Year: 2009
Pages: 39-51
Recent developments in the field of anticancer metallopharmaceuticals
Sanjay Kumar Bharti* and Sushil K. Singh,
Publication Type: Journal Article (International)
Journal: International Journal of PharmTech Research
Volume: 1
Year: 2009
Pages: 1406-1420
Antidepressant activity of ethanolic extract of Euphorbia thymifolia Linn. in the forced swimming test in rats
S. K. Singh*, T. Prabha, B. Kavitha, H. S. Chouhan and Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Pharmacologyonline
Volume: 2
Year: 2009
Pages: 967-970
Anti-inflammatory and Hepatoprotective activities of ethanolic extract of Euphorbia thymifolia Linn.
S. K. Singh*, T. Prabha, B. Kavitha, H. S. Chouhan and Sanjay Kumar Bharti
Publication Type: Journal Article (International)
Journal: Pharmacologyonline
Volume: 1
Year: 2009
Pages: 986-994
